Finance
Novo-Backed Drugmaker Avalyn Soars 44% After $300 Million US IPO
Avalyn Pharma Inc. shares jumped 44% in its trading debut, after the biopharmaceutical company raised $300 million in an upsized US initial public offering.
B
Bloomberg
April 30, 2026·1 min read
Image: Bloomberg
Avalyn Pharma Inc. shares jumped 44% in its trading debut, after the biopharmaceutical company raised $300 million in an upsized US initial public offering.
Original article
Novo-Backed Drugmaker Avalyn Soars 44% After $300 Million US IPO
Published by Bloomberg